Answers are grounded in this paper and cite their sources.
Infected wounds, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA), often result in dysfunctional healing and fibrotic scarring. This study investigates whether a flexible dielectric barrier discharge cold atmospheric plasma (DBD-CAP) device improves healing quality in MRSA-infected murine full-thickness wounds. Mice were treated with DBD-CAP for 2 min every 48 h, and wound tissues were assessed at days 3, 7, 14, and 21. DBD-CAP treatment significantly reduced bacterial burden and inflammatory infiltration without altering macroscopic closure kinetics. In this improved microenvironment, histological analysis revealed restored basal-restricted integrin α5 polarity and ordered Ki-67 proliferation, indicating a higher quality of re-epithelialization. DBD-CAP also resulted in early angiogenesis at day 7, followed by vascular remodeling at day 14, and led to a lower collagen I/III ratio, smaller scars, and hair regrowth by day 21. Infrared thermography confirmed absence of significant thermal elevation, and repeated exposure showed no systemic toxicity. These results suggest that resolving infection with DBD-CAP creates a favorable microenvironment associated with high-quality, anti-fibrotic tissue repair, independent of accelerated closure speed. While the current experimental design cannot isolate whether these benefits are a direct regenerative effect of the plasma or a secondary, natural healing process resulting from bacterial clearance, this study provides phenotypic evidence for plasma-based wound therapy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: